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Cholesterolinfluencesion-channelfunction,distributionandclusteringinthemembrane,endocytosis,and
exocytic sorting of the nicotinic acetylcholine receptor (AChR). We report the occurrence of a cholesterol
recognition motif, here coined ‘‘CARC’’, in the transmembrane regions of AChR subunits that bear
extensive contact with the surrounding lipid, and are thus optimally suited to convey cholesterol-mediated
signaling from the latter. Three cholesterol molecules could be docked on the transmembrane segments of
each AChR subunit, rendering a total of 15 cholesterol molecules per AChR molecule. The CARC motifs
contribute each with an energy of interaction between 35 and 52 kJ.mol
21, adding up to a total of about
200 kJ.mol
21 per receptor molecule, i.e. 40% of the lipid solvation free energy/ AChR molecule. The CARC
motif is remarkably conserved along the phylogenetic scale, from prokaryotes to human, suggesting that it
could be responsible for some of the above structural/functional properties of the AChR.
W
ithin the superfamily of ligand-gated ion channels, the Cys-loop family comprises several evolutio-
narily related neurotransmitter receptor proteins, coded by a few hundred genes which function as
transducers of various chemical signals. The family includes the nicotinic acetylcholine receptor
(AChR), the subtype 3 of the 5-hydroxytryptamine (serotonin, 5-HT3) receptor, and the glycine and gamma
aminobutyric acid type A (GABAA) receptors. Of these, the AChR, a cation selective channel, is one of the best
characterized members
1. Structurally, AChRs are transmembrane (TM) proteins predominantly localized at the
postsynaptic membrane ofchemically excitable synapses, althoughsome of thesemacromolecules are alsofound
in the presynaptic nerve terminals or in neuronal somas. Extensive experimental evidence supports the view that
cholesterol, avery abundant component of the postsynaptic membrane,modulates the functional properties and
distribution of the AChR protein
2,3. The mechanisms by which cholesterol-AChR interactions translate into the
observedchangesinthereceptor’sligandbindingaffinity
4orionchannelproperties
5arestillnotfullyunderstood.
Attempts to identify cholesterol binding sites on the AChR have mainly relied on the use of photoaffinity
labeling techniques. Initial experiments using chemically reactive cholesterol analogs led to the identification of
theindividualAChRsubunitstargetedbytheseprobes
6,7.Subsequentstudieswithphotoactivatablesterols,which
arenotnecessarilybonafidefunctionalcholesterolsubstitutes,haveprovidedfurtherinsightintoputativeregions
of the AChR involved in interactions with cholesterol; the label was found in peptides that contain almost
exclusively the a-TM4, a-TM1 and c-TM4 membrane spanning segments
8,9. More recent photoaffinity labeling
studies using azido-cholesterol analogs led to the identification of putative cholesterol-AChR interaction sites on
theTMsegmentsTM4,TM3,andTM1ofeachsubunit,withTM4havingthegreatestinteractionwithmembrane
cholesterol, and in all cases fully overlapping the lipid-protein interface of the AChR
10.
It has been reported that many proteins that interact with cholesterol possess an amino acid consensus
sequence termed ‘‘CRAC’’ (cholesterol recognition/interaction amino acid consensus) in their juxtamembrane
region, with the pattern –L/V–(X)(1–5)–Y–(X)(1–5)–R/K–, where (X)(1–5) represents between one and five
residues of any amino acid
11–14. As a consequence of such a broad definition its occurrence is very high in many
proteomes, so that the mere presence of CRAC does not indicate the occurrence of specific protein-cholesterol
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13. The CRAC sequence has been suggested to relate
to the propensity of membrane proteins to be incorporated into
cholesterol-rich lipid domains
14 and also to promote the segregation
of cholesterol into lipid domains
15. Given the profound modulatory
effects of cholesterol on the structural and functional properties of
theAChRweundertookasearchforthisregioninAChRaminoacid
sequences. Indeed, the sequence was found to be present in virtually
all AChR muscle-type AChR subunits in a region immediately adja-
cent to the TM1 transmembrane domain (Fig. 1). The CRAC
domain, however, was found in segments of the AChR polypeptide
chain that stretch out of the membrane bilayer, and hence are prob-
ablynotthe energetically most favorable partners forcholesterol ina
hydrophobic membrane environment.
Inthecourseofouranalysis,moredetailedinspectionoftheAChR
sequences disclosed the occurrence of a new potential cholesterol-
recognizing domain with a motif similar to the CRAC sequence but
oriented in the opposite direction along the polypeptide chain, con-
stituting an ‘‘inverted CRAC’’ domain, for which reason we coined
it ‘‘CARC’’ sequence (Fig. 1). In contrast to CRAC, a search in the
AChR family revealed that the newly found CARC motif is totally
embedded in the membrane bilayer region and thus appears more
suitable for interaction with membrane-bound cholesterol than
CRAC. Furthermore, the CARC motif is found to be evolutionarily
conserved among members of the AChR family, from prokaryotes
to Homo sapiens, and is also present in other members of the Cys-
loop family and its bacterial homologs as well as in members of the
important family of G-protein coupled receptors.
Results
Initial studies in search of the so-called ‘‘CRAC’’ domain in AChR
amino acid sequences, postulated to interact with cholesterol
13,14,
revealed its presence in almost all subunits of human muscle-type
AChR in a region immediately adjacent to TM1 and in mouse TM1
(Fig. 1 and Supplementary Fig. S1 online). The CRAC sequence,
which is present in proteins such as caveolin-1
13,16, was found to
occur in the extramembranous amino-terminal region of the
AChR but was conspicuously absent from some subunits such as c
in the Torpedo AChR, d in human muscle AChR, or the a4 subunit
in human neuronal AChR (Fig. 1 and Supplementary Fig. S1
online). The CRAC sequence spans amino acids in the TM region
and beyond, extending into the extramembranous domain of the
AChR.
A closer look at the AChR sequences disclosed that immediately
adjacent to the CRAC sequence, a mirror or ‘‘inverted’’ sequence
follows within the membrane-embedded region of the AChR, which
werefertoasthe"CARC"motif.Indeed,theCARCsequenceisfound
intheTM1segmentsofhumanandmousemuscleAChRsubunitsas
well as in Torpedo sp. (with the exception of the c subunit for the
three above-mentioned species) and in neuronal a7 and a4 AChR
subunits (Fig. 1 and Supplementary Fig. S1 online). CARC is also
found in other members of the Cys-loop family (Supplementary Fig.
S1 online). Interestingly, the CARC domain is present in the TM1 of
two prokaryote pentameric channel homologs of the AChR, the
proteins ELIC and GLIC (Supplementary Fig. S1 online), found in
Erwinia chrysanthemi and Gloeobacter violaceus, respectively
17,18.
It is also interesting to note that the CARC sequence satisfies
several other criteria to qualify as a cholesterol binding motif: i)
CARC is present in TM1, a receptor region firmly established as a
membrane-spanning domain and, more importantly, to interact
with membrane lipids
19; ii) there appears to be a good correlation
between the amino acids in the CARC motifs in the AChR subunits
and some of the residues in TM1 recently postulated by Brannigan
et al.
20 to be involved in AChR-cholesterol interactions. iii) In
addition, the Asp residue at the N-terminal region of the bTM4
segment, postulated by Hamouda et al.
10 to interact with cholesterol,
is immediately adjacent to the CARC segment.
In order to further define whether the proposed CARC domain is
an energetically plausible cholesterol-binding motif we employed
molecular modeling techniques to analyze possible interactions
between cholesterol and the AChR, using the molecular coordinates
of the Torpedo AChR (PDB 2bg9 ref.
21) as a template for the human
receptor.
Optimal fit of cholesterol on the CARC domain of a1TM1. The
CARC domain of human a1TM1 is defined as
209RLPLYFIV
216 (the
underlined amino acids belonging to the TM domain). The defini-
tion of the motif is based on a triad of basic (R or K), aromatic (Y),
and aliphatic (L or V) residues. Two distinct cholesterol molecules
(Chol 1 and Chol 2) fit onto this motif. Because of its charged
characteristics, the basic residue (R-209) is located outside the TM
domain (see Supplementary Fig. S2 online). Its side chain is oriented
towards the same side as the aromatic side chain of Y-213. Although
the -OH group of cholesterol could theoretically interact with any of
these polar side chains, obviously it can only interact with one. An
interaction with R-209 is unlikely because once the -OH group of
cholesterol is bound to the guanidinium cation, there is no other
available polar group in the cholesterol molecule to accommodate
Figure 1 | (A) Scheme depicting the whole AChR protein molecule
inserted in the plasma membrane (left), an individual subunit of the
pentamer, showing the four (TM1 to TM4) transmembrane segments
(middle), and the amino acid sequence of a single TM domain,
corresponding to the human muscle TM1 (right). All subunits possess a
relatively large extracellular amino terminal domain, four TM segments
(TM1 to TM4), a large intracellular loop between TM3 and TM4, and a
short extracellular C-terminus portion. The CRAC and CARC regions are
indicated in the scheme. (B) Alignment of the TM1 (highlighted in gray)
amino acid sequences of human muscle and neuronal (a7 and a4)
AChR subunits. The cholesterol recognition/interaction amino acid
consensus (CRAC) motif [2L/V2(X)(125)2Y2(X)(125)2R/K2]
is highlighted in yellow. CARC, the inverted CRAC sequence,
([2R/K2(X)(125)2Y2(X)(125)2L/V2]) is indicated by bold red
letters. See text for details.
www.nature.com/scientificreports
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of cholesterol (i.e. Chol 2) and Y-213 is far more likely (Fig. 2). The
energy of interaction between Chol 2 and Y-213 was found to be
27.430 kJ.mol
21. There is no other contact between Chol 2 and
any other amino acid residue of the CARC domain, yet the fit
between Chol 2 and TM1 is quite good, with a total energy of inter-
actionof229.803 kJ.mol
21.However,asecondcholesterolmolecule
(Chol 1) could be positioned on the opposite face of TM1,
establishing several tight contacts with CARC amino acid residues:
L-212 (27.476 kJ.mol
21), I-215 (216.405 kJ.mol
21), and V-216
(23.960 kJ.mol
21). The total energy of interaction between Chol 1
and TM1 is 235.129 kJ.mol
21, a significantly better fit than the
223.318 kJ.mol
21 value calculated from the model obtained in
ref. 20, which also places a cholesterol molecule in TM1. It should
be noted that the best fit has been found for the a face of Chol 1 and
the b face of Chol 2
22. If one tries the symmetric orientations (i.e. b
face for Chol 1 and a face for Chol 2) the energy of interaction
decreases in both cases, indicating a worse fit for TM1.
The obvious question arises: can the whole AChR protein accom-
modate both Chol 1 and Chol 2? To answer this question, the calcu-
lated ternary complex [Chol1-TM1-Chol2] was modeled onto the
human AChR structure derived from 2bg9. A clear steric clash
became apparent between Chol 2 and the bTM2 domain. This sug-
gests that TM1 can accommodate only one cholesterol molecule,
Chol 1. Accommodating a second cholesterol molecule, Chol 2, pro-
duces a serious and unacceptable distortion of the protein.
Unfavorable docking of cholesterol on a1TM2. TM2 is the
channel-lining, innermost ring of TM segments of the AChR. It
does not possess a CARC domain. Two cholesterol molecules
could be docked onto the TM2 transmembrane domain (Supple-
mentary Fig. S3 online): one on the extracellular-facing leaflet of
the bilayer (Chol 1), and the other on the intracellular leaflet
(Chol 2) of the plasma membrane. However, the fit between TM2
and Chol 1 is significantly weaker than with other TM segments
(217.139 kJ.mol
21). In contrast, the fit with Chol 2 is significantly
better(231.695 kJ.mol
21),essentiallybecauseofthepossibilityofan
H-bond between the -OH group of Chol 2 and the -OH group in the
side chainof T-244 (overall the energyof interaction between Chol2
and T-244 is 210.074 kJ.mol
21, i.e. one third of the total energy
of interaction. See Discussion for more details). In spite of the
theoretical possibility of establishing Chol-TM2 contacts, none of
the two cholesterol molecules are likely to interact with the intact
AChR protein, since both overlap with the a1TM1 domain.
Dockingofcholesterolona1TM3.ThereisnostrictCARCdomain
in TM3, unless the domain definition permits replacement of a Y
residue by an F residue. Indeed, the TM3 domain displays a
276KYMLFTMV
283 ‘‘CARC-like’’ sequence (the ‘‘CARC-like’’ motif
is operationally defined as follows: [R/K]–[X](1–5)–[F]–[X](1–5)–
[L/V]). Cholesterol could be docked onto this motif, with a total
energy of interaction of 231.729 kJ.mol
21. Most of the interaction
involves amino acid residues belonging to this CARC-like domain
(Fig. 3). Moreover, the Chol-TM3 complex is fully consistent with
the AChR structure.
Docking of cholesterol on a1TM4. An energetically favorable fit
was also found between TM4 and cholesterol (227.903 kJ.mol
21).
The sequence interacting with cholesterol lies between amino acid
residues M-415 and F-426, resembling a ‘‘CRAC-like’’ motif
423LAVFAGR
429 (Fig. 3), i.e. the CRAC motif with an F instead of a
Y residue in the sequence: [L/V]–[X](1–5)–[F]–[X](1–5)–[R/K].
This fit is also consistent with the AChR structure.
Docking of cholesterol molecules to the whole AChR and
energetics of cholesterol-AChR interactions. As shown in Fig. 4,
a total of fifteen cholesterol molecules could be accommodated
around the belt of the AChR macromolecule, in accordance with
early work by Narayanaswami and McNamee
23 and Mantipragada
et al.
24. This molecular arrangement does not produce distortions
of the whole AChR molecular structure. The free energy of inter-
action between cholesterol molecules and the AChR is about
Figure 2 | Docking of two cholesterol molecules on human AChR a-TM1. Two cholesterol molecules (Chol 1 and Chol 2) were docked on the aTM1
domain of the human AChR as described in Materials and Methods. A detailed analysis of the energy of interaction of each cholesterol-TM1 complex is
shownontheleftpanel(A).Atuberenderingofthemodelisshownin(B).Thea-helixoftheTMdomainiscoloredingreen.TheapolarpartofChol1(in
yellow)interactswithIle212,Ile215,andIle219(vanderWaalsinteractions),whereasitspolarpart(theOHgroup)islocatedattheapolar-polarinterface
of the membrane where it can interact with water molecules. The OH group of Chol 2 (in violet) forms an H-bond with the phenolic OH of Tyr213. The
surfacecomplementaritybetweenthea-TM1domainandChol2(inyellow)isillustratedbyasurfaceviewofthecomplex(C).Theelectrostaticsurfaceof
the a-TM1 domain is rendered in blue for positive, red for negative, and grey for neutral regions, respectively.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 1 : 69 | DOI: 10.1038/srep00069 3Figure 3 | Dockingofcholesterolona-TM3anda-TM4domainsofthehumanAChR. Thepredictedinteractionbetweencholesterolanda-TM3relies
exclusivelyonvanderWaalsinteractionsinvolvingaliphaticresidues(Leu279,Val283)andthearomaticPhe280(A).Thegeometryoftheiso-octylchain
ofcholesterolisconsistent withabendthatisnecessarytoadaptthe formofthelipidmoleculetothe crevicesofthe a-TM3domainasshowninboththe
tube(B)andsurfacerenderings(C).Inthea-TM4/cholesterolcomplex,cholesterolisnotonlybentbutalsotwistedonitsmainaxis,allowinganoptimal
fitfora-TM4(E,F).Asfora-TM3,thiscomplexischieflystabilizedbyvanderWaalsinteractionsinvolvingbothaliphatic(Ile419,Leu423)andaromatic
(Phe426) residues (D).
Figure 4 | Docking of 15 cholesterol molecules onto the whole human AChR. (A) End-on view ribbon rendering of the human AChR (a2bde) with 15
cholesterol molecules (grey), in contact with the outer ring
29, made up of TM4 segments (red), and middle ring, made up up TM1 (yellow) and TM3
(blue)transmembranesegments.Notethattheinnerring,whichlinesthewallsoftheionchannel(TM2domains,green),doesnotestablishcontactwith
cholesterol molecules. (B) Side view of the human AChR (in grey) with energy-minimized cholesterol molecules (red) docked on the surface of its
transmembrane region.
www.nature.com/scientificreports
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21, i.e. more than 2100 kJ.mol
21 per subunit.
The particularly good fit between the ‘‘CARC-like’’ cTM4 domain
from human AChR (
428RVCFLAML
435) and cholesterol is note-
worthy, with an energy of interaction of about 260 kJ.mol
21, i.e.
,60% of the total energy of interaction of the entire c subunit,
which exhibits the highest affinity for cholesterol (cf. Table 1).
Presence of CARC domains in G protein-coupled receptors
(GPCRs). Is the CARC motif exclusive to the Cys-loop receptor
superfamily? To address this question, we investigated its presence
in another very important group of membrane proteins, the G-
protein coupled receptors (GPCRs), which are documented to inter-
act with cholesterol in lipid microdomains
25. Indeed, the CARC
domain is conspicuously present in the GPCR superfamily (Supple-
mentary Fig. S4 online). We further narrowed down the search to
GPCRsinvolved inAlzheimer’sdisease
25,26,becauseofthepurported
link between neuronal AChRs and cholesterol in this pathology
27.
Asshown in Supplementary Fig. S4B (online), the CARC and CRAC
domains are present in GPCRs involved in Alzheimer’s disease. In
order to quantify the degree of interaction between cholesterol and
the CARC domain in GPCRs we chose a TM domain of the
somatostatin receptor (Supplementary Fig. S5 online) known to
interact with cholesterol
28. Interestingly, this GPCR was found to
contain CARC and CRAC sequences in the same TM segment
(Figs. S4B–S5). As shown in Supplementary Fig. S5 (online), both
CARC and CRAC domains bind cholesterol with high affinity, the
interaction with CARC being 23% stronger.
Discussion
In the present work we show the existence of CARC, CARC-like and
CRAC-likeaminoacidconsensuspatternsintheTMsegmentsofthe
AChR that are ideally suited to interact with cholesterol molecules
present in the vicinal lipid microenvironment of the macromol-
ecule
2,3. These interaction sites are in full accordance with published
experimentaldata
2,29.Amorerecentproposal
20isbasedontheobser-
vation of "gaps" in the electron density maps of the AChR cryoelec-
tron microscopy images of Unwin and colleagues
21:u pt o5
cholesterol molecules could be accommodated into these deeply
buried inter-subunit "holes", with a total of 15 cholesterol molecules
per receptor molecule. Both Hamouda et al.
10 and our laboratory
24
had calculated the same number of cholesterol molecules from inde-
pendent photolabeling and electron spin resonance experimental
data, respectively, but unlike the deeply buried cholesterols postu-
lated from in silico calculations in the more recent proposal
20, all
the cholesterol molecules readily exchange with bulk lipids
10,24
(Supplementary Fig. S6 online).
Three cholesterol molecules could be docked on the transmem-
brane segments TM1, TM3 and TM4 of each of the five human
AChR subunits, with energies of interaction per subunit ranging
between 290 and 2130 kJ.mol
21 (Table 1). The highest energe-
tic contribution stemmed from the CARC domains in the TM1
segments, each with an energy of interaction between 35 and
52 kJ.mol
21, adding up to a total of about 200 kJ.mol
21 per AChR
molecule, that is, ca. 40% of the total lipid solvation free energies for
the whole AChR molecule
30.
The best fit was found for the CARC-like motif present in the
human AChR cTM4 segment (Table 1). The latter constitutes an
exceptional case, in as much as it supplies an energy of interaction
(260 kJ.mol
21) amounting to roughly half the total energy contrib-
uted by the other TM segments in the c subunit, which incidentally
provides the highest energetic contribution of all subunits (Table 1).
The AChR cTM4 segment exhibits other interesting features: in a
pure phospholipid (phosphatidyl-oleoyl phosphatidylcholine) sys-
tem in the ld phase, cTM4 was found to occur as an isolated peptide,
matching the hydrophobic region of the bilayer; in contrast, if the
same phospholipid system contains cholesterol (and is thus in the lo
phase) cTM4 maximizes homophilic hydrophobic interactions and
forms bundles with other cTM4s
31.
The CARC domain identified in TM1 exhibits a comparable or
evenhigherenergyofinteractionthanthevaluesfoundforlipophilic
xenobioticssuchasgeneralanestheticsintheAChR
32.Theenergetics
of interaction between CARC in TM1 and cholesterol do notinvolve
any H-bond, but rather van der Waals interactions among choles-
terolandnon-polarsidechainsinTM1.Severalotherfitsweretested
between cholesterol and TM domains, but most of them resulted in
stericclashes,implyingthattheAChRproteincouldnotaccommod-
ate more cholesterol molecules without significant structural distor-
tions. A recent study employing molecular dynamics simulations
disclosed interactions between cholesterol and the TM1 and TM4
segments of the neuronal (a4b2) subtype of AChR
33. It is worth not-
ing that the amino acids identified by these authors fit very well with
the CARC consensus motif disclosed in the present work.
The TM3-cholesterol complex involves a ‘‘CARC-like’’ domain
in which the aromatic Tyr residue is replaced by Phe, another aro-
matic residue. A similarly ‘‘F/Y’’ modified ‘‘CRAC-like’’ domain is
also involved in the interaction between cholesterol and TM4. As
mentioned above, the best fit in the present study was obtained with
the CARC motif present in TM1. Overall, the energy of interaction
between cholesterol and individual amino acid residues in human
AChR TM domains are compatible with previous values calculated
foranunrelatedcholesterolbindingsite
34.Forinstance, ourvaluesof
29.228 kJ.mol
21 for I-419 in TM4 and 216.405 kJ.mol
21 for I-215
in TM1 are consistent with the 210.032 and 210.868 kJ.mol
21 cal-
culated for I-167 and I-203 respectively in the Osh4 protein.
The molecular mechanisms underlying the physical interaction
betweencholesterolandCARC/CARC-likedomainswarrantfurther
experimental study. Inspection of the specific amino acid require-
ments of the CARC/CARC-like consensus motif already reveals sev-
eral interesting features. The motif is based on a sequence of amino
acids which includes, from the N-term to C-term endings, a basic
Table 1 | Energetics of interaction of cholesterol and the CARC,
CARC-like and CRAC-like motifs in the transmembrane domains
of human muscle-type AChR.
AChR TM domain Energy of interaction (kJ.mol
21)
aTM1 235.129
aTM3 231.729
aTM4 227.903
Total a subunit 294.761
bTM1 252.332
bTM3 220.808
bTM4 226.241
Total b subunit 299.453
cTM1 230.542
cTM3 237.066
cTM4 259.961
Total c subunit 2127.569
dTM1 246.184
dTM3 233.083
dTM4 229.197
Total d subunit 2108.464
eTM1 244.438
eTM3 224.421
eTM4 244.050
Total e subunit 2112.909
Embryonic AChR
1 (a2bcd) 2525.008
Adult AChR
1 (a2bed) 2510.348
1The stoichiometric contribution of two a subunits is taken into account in the estimation of the total
energy of interaction of the AChR pentamer with cholesterol molecules.
www.nature.com/scientificreports
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However, this does not imply that all these residues interact with
cholesterol. Indeed, there is no evidence in our modeling studies of a
directinteractionbetweenthebasicresidueofCARCandcholesterol.
Instead, we assume that the presence of K/R ensures that the CARC
motif is correctly positioned at the polar-apolar interface of a TM
domain, just where cholesterol is supposed to be. This is due to the
‘snorkeling’ effect
35 which is attributable to the burial of the long
and flexible side chain of Lys (or Arg) in the hydrophobic region
of the membrane, whereas the cationic e-NH3
1 group ‘breathes’ at
themorepolarinterfaceregion
36.Asaconsequenceofthis,ifLysand
Argresiduesaresnorkeling,theycanbepresentinaTMdomainand
be followed by several hydrophobic residues which also reside in the
membrane. In addition, since arginine and lysine residues are more
frequently found in the N-terminal than in the C-terminal third of
a TM domain, snorkeling is an asymmetric phenomenon
36. The
specific topology of the CARC sequence (K/R…Y/F…L/V, from
the N-terminus to the C-terminus) implies that the key residues
following K/R in the motif (i.e. Y/F and L/V) actually belong to a
TMdomain.Therefore, even if thereisno direct interaction between
cholesterol and K/R, the basic amino acid in the first position is
critical for identifying a functional CARC motif belonging to a TM
domain. Incidentally, this also explains why the CRAC motif, which
has an inverse topology (L/V…Y… K/R, fromthe N-terminus to the
C-terminus), does not always belong to a TM domain
14. Moreover,
theTyrresidue(anabsoluterequirementinthecaseofCRAC)canbe
replacedbyPheintheCARCmotif.SinceCRACisajuxtamembrane
motif,thephenolgroupofTyrisrequiredtoformaH-bondwiththe
OH group of cholesterol
14, and this would not be possible with Phe.
In the case of CARC, the interaction between the aromatic amino
acidandcholesteroloccursintheapolarregionofthemembrane,far
from the OH group of cholesterol. Thus the interaction with choles-
terol is mediated by the stacking between the aromatic ring of the
amino acid (either Y or F) and one of the cycles of cholesterol. The
energy of interaction between the aromatic amino acids of AChR
TM3andTM4domainsisabout25 kJ/mol,whichisfullyconsistent
with this type of interaction. Finally, the requirement for L/V is
justified by the need to accommodate the crevices and asperities of
the cholesterol molecule
22 and there are numerous van der Waals
contacts between these residues and cholesterol in the TM domains
of the AChR (Figs. 2–4).
The newly discovered consensus cholesterol-recognition motif,
CARC, covers a wide evolutionary span, ranging from the fairly
‘‘recent’’ Torpedo sp. to Homo sapiens and even to the bacterial
pentameric channels, structural
17,18,37,38 homologs of the AChR
recently found in prokaryotes, i.e. the cyanobacterium Gloebacter
violaceous and its orthologue from Erwinia chrysanthemi. Even
though the presence of cholesterol in the plasma membrane is an
almost exclusive attribute of eukaryotes, there are a few examples of
the presence of sterols in bacteria
39,40. Cyanobacteria possess hopa-
noids, which are structurally and functionally similar to sterols
40.
Thus, the preservation of the CARC motif through such a wide span
in the evolutionary scale -from prokaryotes to humans- could indi-
cate that this domain has an important structural and/or functional
role.Insupportofthishypothesisistheextensiveexperimentalwork
showing that mutations in amino acids in the transmembrane
regions of the AChR alter channel gating (see review in
41). Inter-
estingly, some of these functionally relevant mutations are very close
to or within CARC/CARC-like domains. Another possibility is that
this motif initially had no functional properties in prokaryotic
AChR-likeproteins,butuponappearanceofcholesterolinthecourse
of phylogeny it acquired a role in higher organisms for transducing
regulatory signals from the adjacent plasma membrane lipid moiety
to the protein moiety. We would like to entertain the idea that the
CARC domain present in the AChR and its bacterial homologues is
involved in some of the observed effects of cholesterol on AChR
function and distribution (see review in
41). Future mutational and
biophysical studies should be oriented to determining the functional
relevance of the CARC motif in the AChR. Finally, we have shown
that the CARC motif is also present in the TM domains of the
important group of GPCRs (Supplementary Figs. S4 and S5 online).
Interestingly,bothGPCRsandAChRarethoughttoplayaroleinthe
pathology of Alzheimer’s disease
25–27. Altogether, these data provide
aninterestinglinkbetweenAlzheimer’sdisease,highcholesterol,and
neurotransmitter receptors including AChR and GPCRs displaying
CARC motifs in their TM domains.
Methods
The definition of the motif is based on a triad of basic (R or K), aromatic (Y), and
aliphatic (L or V) residues along the primary sequence. Search for the presence
and localization of the consensus sequence for the "CRAC" motif, [L/V]–[X](1–5)–
[Y]–[X](1–5)–[R/K]
11–13,15 or the "CARC" motif introduced in the present work,
[R/K]–[X](1–5)–[Y]–[X](1–5)–[L/V], as well as the ‘‘CARC-like’’ motif [R/K]–
[X](1–5)–[F]–[X](1–5)–[L/V] and the corresponding ‘‘CRAC-like’’ motif [L/V]–
[X](1–5)–[F]–[X](1–5)–[R/K], was carried out on the AChR subunits and other
Cys-loop receptor sequences using the Fuzzpro application of the Jemboss software
(European Molecular Biology Open Software Suite, EMBOSS). The same procedure
was also applied to analyze the sequences of the large family of G-protein coupled
receptors (GPCRs).
To analyze the interaction between cholesterol and the TM domains of the AChR
we applied a modeling procedure derived from the fragment-based approach
42. The
TM domains of the human AChR protein (Swiss-Prot entries P02708, P11230,
P07510, Q07001, and Q04844 respectively for the a,b,c,d, and e subunits) were
generated by structural homology modeling with the Swiss-Pdb modeling software,
using the molecular coordinates of the Torpedo AChR (PDB No. 2bg9, ref. 21) as a
template. Cholesterol-TM complexes were then modeled with Hyperchem 8
(Hypercube Inc. Gainesville, FL). In each case, one cholesterol molecule was initially
positioned in the vicinity of the TM domain to undertake the manual search for
geometric fit. Geometry optimization of each cholesterol-TM complex was first
achieved using the unconstrained optimization rendered by the Polak-Ribie `re con-
jugategradientalgorithm
43.Moleculardynamics simulations werethenperformedin
vacuo for 10 ns with the Bio1 (CHARMM) force field of the Hyperchem 8 software
suite
34. The ligand (cholesterol)-protein energy of interaction was determined with
the Molegro Molecular Viewer. Briefly, the piece-wise linear potential method was
applied
44. The method takes into account two different sets of parameters: one set for
approximating the steric (van der Waals) term between atoms and another set for
stronger potentials (hydrogen bonds). Several initial conditions were tested (with
distinct orientations of cholesterol with respect to the given TM domain) to select
those cholesterol-TM complexes having the highest energy of interaction. Individual
cholesterol-TMcomplexeswerethensuperimposedstep-by-stepwiththestructureof
the AChR protein using the fit menu of the Swiss-Pdb program. This allowed us to
identify any potential steric clash induced by the presence of cholesterol molecules
bound to the receptor. Fine conformational tuning was performed with Hyperchem
8 to generate the final model of the human AChR protein complexed with 15
cholesterol molecules.
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